SCHEDULE 13D

Company

Actinium Pharmaceuticals, Inc.

Filed

January 18, 2013

Accession Number

0001188112-13-000127

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →